In a fascinating study on the past, present and future of gene therapy for ED, Melman and Davies write extensively about the positive results of the phase I trial of the new Maxi-K treatment and how it compares to other therapies:


"Gene Therapy in the Management of Erectile Dysfunction (ED): Past, Present,
and Future

Arnold Melman* and Kelvin P. Davies

Department of Urology, Albert Einstein College of Medicine, Bronx, NY

Published August 31, 2009

In the past, many researchers considered viral vectors to be the most promising candidates to transfer genetic material into the corpora for the treatment of erectile dysfunction. However, at present, no viral vectors have progressed to human trials. In contrast, the use of naked gene therapy, a plasmid expressing the human Maxi-K potassium channel, is the only gene therapy treatment to be evaluated in clinical phase I trials to date. The success of these studies, proving the safety of this treatment, has paved the way for the development of future gene transfer techniques based on similar transfer methods, as well as novel treatment vectors, such as stem cell transfer."


You can read the full text here:

http://www.ionchannelinnovations.com...rapy_TSW09.pdf